Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Schaefer

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patientsH G Schaefer, H Stass, J Wedgwood, et al.
British Journal of Clinical Pharmacology|February 13, 2001
Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failureL Brynne, J L McNay, H G Schaefer, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
Comparison of manual versus ambulatory blood pressure measurements with pharmacokinetic-pharmacodynamic modeling of antihypertensive compounds: application to moxonidineI F Trocóniz, D P de Alwis, C Tillmann, et al.
Journal of the American College of Cardiology|December 31, 1997
Dose-related hemodynamic and electrocardiographic effects of the calcium promoter BAY y 5959 in the presence or absence of congestive heart failureM F Rousseau, P E Massart, C van Eyll, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Antimicrobial Agents and Chemotherapy|January 1, 1996
Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patientsH G Schaefer, H Stass, J Wedgwood, et al.
British Journal of Clinical Pharmacology|February 13, 2001
Pharmacodynamic models for the cardiovascular effects of moxonidine in patients with congestive heart failureL Brynne, J L McNay, H G Schaefer, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
Comparison of manual versus ambulatory blood pressure measurements with pharmacokinetic-pharmacodynamic modeling of antihypertensive compounds: application to moxonidineI F Trocóniz, D P de Alwis, C Tillmann, et al.
Journal of the American College of Cardiology|December 31, 1997
Dose-related hemodynamic and electrocardiographic effects of the calcium promoter BAY y 5959 in the presence or absence of congestive heart failureM F Rousseau, P E Massart, C van Eyll, et al.
Pageof 5